[go: up one dir, main page]

UY31204A1 - Derivados de macrolactona - Google Patents

Derivados de macrolactona

Info

Publication number
UY31204A1
UY31204A1 UY31204A UY31204A UY31204A1 UY 31204 A1 UY31204 A1 UY 31204A1 UY 31204 A UY31204 A UY 31204A UY 31204 A UY31204 A UY 31204A UY 31204 A1 UY31204 A1 UY 31204A1
Authority
UY
Uruguay
Prior art keywords
macrolactone
dsm
microorganism
derivatives
formula
Prior art date
Application number
UY31204A
Other languages
English (en)
Inventor
Schummer Dr Dietmar
Kogler Dr Herbert
Klemke-Jann Dr Christine
Hoffmann Dr Holger
Original Assignee
Sanofi Aventis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis filed Critical Sanofi Aventis
Publication of UY31204A1 publication Critical patent/UY31204A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D273/00—Heterocyclic compounds containing rings having nitrogen and oxygen atoms as the only ring hetero atoms, not provided for by groups C07D261/00 - C07D271/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
    • C07K5/0808—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Derivado de la macrolactona de la fórmula (I), en donde X e Y, son tales como se definieron en la Memoria Descriptiva y en las reivindicaciones o su sal fisiológicamente tolerable, formada por el microorganismo ST 201196 (DSM 18870), su uso para el tratamiento y/o la profilaxis de trastornos fúngicos, medicamentos que comprenden un compuesto de la fórmula (I), procedimientos para su preparación, y el microorganismo ST 201196 (DSM 18870).
UY31204A 2007-07-04 2008-07-02 Derivados de macrolactona UY31204A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP07290841 2007-07-04

Publications (1)

Publication Number Publication Date
UY31204A1 true UY31204A1 (es) 2009-01-30

Family

ID=38508880

Family Applications (1)

Application Number Title Priority Date Filing Date
UY31204A UY31204A1 (es) 2007-07-04 2008-07-02 Derivados de macrolactona

Country Status (22)

Country Link
US (1) US8268775B2 (es)
EP (1) EP2173756B1 (es)
JP (1) JP5539193B2 (es)
KR (1) KR20100031716A (es)
CN (1) CN101687884B (es)
AR (1) AR071538A1 (es)
AT (1) ATE502039T1 (es)
AU (1) AU2008271631B2 (es)
BR (1) BRPI0812827A2 (es)
CA (1) CA2692260A1 (es)
CL (1) CL2008001973A1 (es)
DE (1) DE502008002892D1 (es)
DK (1) DK2173756T3 (es)
ES (1) ES2362814T3 (es)
IL (1) IL202990A (es)
MX (1) MX2009014204A (es)
MY (1) MY146954A (es)
PA (1) PA8787001A1 (es)
PE (1) PE20090736A1 (es)
PT (1) PT2173756E (es)
UY (1) UY31204A1 (es)
WO (1) WO2009003595A2 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010069850A1 (en) * 2008-12-17 2010-06-24 Sanofi-Aventis Macrolactone derivatives, method for the production thereof and use thereof for the treatment of cancer
US11230553B2 (en) 2016-05-09 2022-01-25 The Research Foundation For The State University Of New York Nannocystin process and products
CN106083997B (zh) * 2016-07-05 2021-03-26 北京大学深圳研究生院 Nannocystin A及其结构类似物的合成
CN109280073A (zh) * 2017-07-19 2019-01-29 南开大学 Nannocystins衍生物及其用途
CN109796468B (zh) * 2019-03-26 2021-08-31 南开大学 大环nannocystin衍生物、及其制备方法和用途
CN114907367B (zh) * 2022-05-14 2024-06-14 福建省微生物研究所 大环内酯类化合物fw-z、其发酵菌株、发酵方法及应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1226142A2 (en) * 1999-07-22 2002-07-31 Schering Aktiengesellschaft Process for the production of epothiolone b and derivatives as well as intermediate products for this process
AU2006226257A1 (en) * 2005-03-23 2006-09-28 Consejo Superior De Investigaciones Cientificas Polyene antibiotics, compositions containing said antibiotics, method and micro-organisms used to obtain same and applications thereof

Also Published As

Publication number Publication date
DE502008002892D1 (de) 2011-04-28
JP2010531823A (ja) 2010-09-30
MY146954A (en) 2012-10-15
CN101687884B (zh) 2012-10-31
US20100256049A1 (en) 2010-10-07
PT2173756E (pt) 2011-05-23
WO2009003595A3 (de) 2009-04-09
PA8787001A1 (es) 2009-02-09
IL202990A (en) 2013-10-31
CL2008001973A1 (es) 2008-11-03
HK1142888A1 (en) 2010-12-17
DK2173756T3 (da) 2011-07-18
EP2173756A2 (de) 2010-04-14
ES2362814T3 (es) 2011-07-13
EP2173756B1 (de) 2011-03-16
BRPI0812827A2 (pt) 2014-12-09
ATE502039T1 (de) 2011-04-15
MX2009014204A (es) 2010-01-28
US8268775B2 (en) 2012-09-18
AR071538A1 (es) 2010-06-30
JP5539193B2 (ja) 2014-07-02
AU2008271631A1 (en) 2009-01-08
KR20100031716A (ko) 2010-03-24
WO2009003595A2 (de) 2009-01-08
AU2008271631B2 (en) 2013-06-06
CN101687884A (zh) 2010-03-31
CA2692260A1 (en) 2009-01-08
PE20090736A1 (es) 2009-07-17

Similar Documents

Publication Publication Date Title
HN2009000784A (es) Dihidropirazolonas sustituidas
CO6491058A2 (es) Derivados de oxazina y su uso como inhibidores de bace para el tratamiento de trastornos neurológicos
BRPI0720551A2 (pt) composto ou um sal farmaceuticamente aceitável do mesmo, e, uso do mesmo, método para o tratamento de câncer, processos para a preparação de uma composição farmacêutica e de um composto ou de um sal farmaceuticamente aceitável do mesmo
DOP2009000287A (es) Oxazolidinonas sustituidas y su uso
MY148429A (en) Novel 1,4-benzothiepin-1,1-dioxide derivatives which are substituted with benzyl groups, method for producing drugs containing said compounds and use thereof
ECSP078060A (es) 2,4-diamino-pirimidinas como inhibidores de aurora
ECSP088358A (es) Tratamiento y profilaxis de microangiopatías
UY31228A1 (es) Ariloxazoles sustituidos y su uso
TNSN08326A1 (en) Azacyclyl-substituted aryldihydroisoquinolinones, process for their preparation and their use as medicaments
ECSP12012065A (es) Derivados de pirazina y su uso en el tratamiento de trastornos neurológicos
MY149854A (en) Novel aminoalcohol-substituted aryldihydroisoquinolinones, process for their preparation and their use as medicaments
ECSP088749A (es) Compuestos de tetrahidropiridotienopirimidina y procedimientos de uso de los mismos
UY30835A1 (es) 8-alquinilxantinas y derivados
MX2010009645A (es) Derivados novedosos de aminometil benceno.
UY31133A1 (es) "oxazolidinonas sustituidas y su uso"
AR058098A1 (es) Derivados de acidos dicarboxilicos y su uso
CO6341625A2 (es) Derivados de indol como agentes anticáncer
AR062401A1 (es) Uso de derivados del 2,5-dihidroxibenceno para tratar dermatitis
UY31204A1 (es) Derivados de macrolactona
CR10199A (es) Derivados de benzimidazol
CL2011001829A1 (es) 3'-n-desmetil-4''-o-(2-dietilaminoetanoil)-6-o-metil-9a-aza-9a-homoeritromicina a, sus sales y formas cristalinas 1, 2 y 3; proceso de preparacion; uso para tratar enfermedades inflamatorias; composicion farmaceutica; y composicion que ademas comprende otro compuesto activo.
MX2011013869A (es) Agentes antihelminticos y su uso.
ECSP099506A (es) Derivados de 2-quinolinona y 2 quinoxalinona y su utilización como agentes anti bacterianos
UY29416A1 (es) Derivados de ácido pirimidincarboxílico y su uso
UY31143A1 (es) Derivados de [1,10]-fenantrolina para el tratamiento de enfermedades neurodegenerativas o hematologicas

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20130205